stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. NBY
    stockgist
    HomeTop MoversCompaniesConcepts
    NBY logo

    NovaBay Pharmaceuticals, Inc.

    NBY
    AMEX
    Healthcare
    Biotechnology
    EmeryVille, CA, US13 employeesnovabay.com
    $1.95
    +0.36(22.64%)

    Mkt Cap $52M

    $1.16
    $95.80

    52-Week Range

    At a Glance

    AI-generated

    NovaBay Pharmaceuticals, Inc.

    8-K
    NovaBay Pharmaceuticals approved a 2026 Equity Incentive Plan, granted substantial equity awards to executives, entered into new employment agreements, and announced a corporate name change to Stablecoin Development Corporation effective April 2, 2026.

    $52M

    Market Cap

    —

    Revenue

    —

    Net Income

    Employees13
    Fundamentals

    How The Business Makes Money

    NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

    Industry Biotechnology
    Activity

    What Changed Recently

    Management Change
    Mar 31, 2026

    . Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.** ** Equity

    Securities Modification
    Feb 19, 2026

    . Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On February 20, 2026, NovaBay Pharmaceuticals, Inc. (the “Company”) filed a

    Material Agreement
    Jan 19, 2026

    . Entry Into a Material Definitive Agreement. On January 20, 2026, NovaBay Pharmaceuticals, Inc. (the “Company”) entered into an ATM Sales Agreement (the “Sales

    Material Agreement
    Jan 15, 2026

    of this Current Report on Form 8-K. Item 3.02. Unregistered Sale of Equity Securities. The information disclosed in Item 1.01 of this Current Report on Form 8-K

    Financial Results+3 More
    Mar 22, 2026

    , including Exhibit 99.1 hereto, is being “furnished” and shall not be deemed “filed” by the Company for purposes of Section 18 of the Securities Exchange Act o

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    VYNEVYNE Therapeutics Inc.$0.61+0.58%$10M-1.0
    IBOImpact BioMedical Inc.$0.60-1.55%$8M—
    TCRTAlaunos Therapeutics, Inc...$2.93-0.68%$7M-1.7
    KTTAPasithea Therapeutics Cor...$0.77+3.49%$6M-0.4
    RADXRadiopharm Theranostics L...$4.38+1.27%$6M—
    PMCBPharmaCyte Biotech, Inc.$0.68-1.32%$5M-2.0
    VIVSVivoSim Labs, Inc.$1.66+2.16%$4M-2.0
    QNRXQuoin Pharmaceuticals, Lt...$6.96+14.85%$4M-0.3
    Analyst View
    Company Profile
    CIK0001389545
    ISINUS66987P5089
    CUSIP66987P508
    Phone510 899 8800
    Address2000 Powell Street, EmeryVille, CA, 94608, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice